Pilot Randomized Controlled Trial To Assess the Effectiveness of a Heat Risk Reduction Decision Support Platform and Barriers and Facilitators of Its Implementation
Launched by UNIVERSITY OF WASHINGTON · May 6, 2025
Trial Information
Current as of July 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into an online tool called CHaRT, designed to help local health departments better prepare for extreme heat events. The tool provides specific information about health risks related to heat in different neighborhoods, helping health departments identify problems and effective solutions tailored to their community. The trial aims to find out if using CHaRT leads to better outreach and effectiveness in heat-related health activities compared to departments that only receive basic information. Researchers will also explore what helps or hinders health departments from using this tool effectively.
To participate, health departments need to be local (like a city or county) and have some independence in planning heat-related programs. The staff involved should be adults who work on these health initiatives. Children and prisoners cannot participate, and health departments in states where public health is managed only at the state level are also excluded. This trial is not currently recruiting participants, but it seeks to improve community responses to extreme heat, which is an important public health issue.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Local (city or county) health department
- • Local (i.e., city or county) health department with at least partial autonomy to pursue the development and implementation of heat-health activities (i.e., not a state where all public health activities are administered at a state level)
- • Availability of a staff member to participate in all elements of the trial. Local health department staff responsible for planning and implementing programming to protect constituents from extreme heat.
- • Adults whose demographics and health status will mirror those of the general population.
- • Current employees of included health departments aged 18 or greater
- Exclusion Criteria:
- • Being in a state where public health activities are exclusively managed at a state level and not having staff availability to participate
- • Children and prisoners
About University Of Washington
The University of Washington (UW) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust network of interdisciplinary teams, UW fosters collaboration among top-tier researchers, clinicians, and healthcare professionals, aiming to translate scientific discoveries into impactful treatments and interventions. The university is dedicated to ethical research practices and participant safety, ensuring rigorous adherence to regulatory standards in all clinical trials. Through its state-of-the-art facilities and extensive expertise, UW strives to address pressing health challenges and improve patient outcomes on a local and global scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Jeremy Hess, MD, MPH
Principal Investigator
University of Washington
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported